» Articles » PMID: 16207186

Long-term Follow-up Study of 142 Patients with Vitiligo Vulgaris Treated by Autologous, Non-cultured Melanocyte-keratinocyte Cell Transplantation

Overview
Journal Int J Dermatol
Specialty Dermatology
Date 2005 Oct 7
PMID 16207186
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vitiligo vulgaris patients are difficult to treat surgically owing to large area involvement. Larger areas can be treated with the help of in vitro cultured melanocytes. These techniques are complex. In most of the studies published to date the number of patients reported is low and follow-up period short.

Objective: To evaluate long-term efficacy and safety of melanocyte-keratinocyte cell transplantation in large number of vitiligo vulgaris patients.

Methods: A simpler and modified method based on that of Olsson and Juhlin has been used. It uses shave biopsy skin sample up to 1/10th the size of recipient area. Skin sample is incubated, cells mechanically separated using trypsin-EDTA solution, and then centrifuged to prepare a suspension. Cell suspension is then applied to a dermabraded de-pigmented skin area and collagen dressing given to keep it in place.

Results: One hundred and forty-two patients with vitiligo vulgaris were treated and observed for a period up to 6 years. Eighty (56%) patients showed excellent, 15 (11%) showed good, 13 (9%) showed fair and 34 (24%) showed poor repigmentation, which was retained till the end of the respective follow-up period.

Citing Articles

Cryoblebbing with 5-fluorouracil versus cryoblebbing with melanocyte keratinocyte transplant procedure or cryoblebbing alone in treatment of stable vitiligo.

Moftah N, Samaka R, Jamal-Edine A, Mostafa H Arch Dermatol Res. 2025; 317(1):290.

PMID: 39825923 DOI: 10.1007/s00403-024-03735-1.


A Study of Autologous Non-Cultured Epidermal Suspension (NCES) Transplant in Patients with Stable Vitiligo without the Use of NB-UVB.

Chandela M, Khurana V, Mehta R, Saxena A, Mohanty S, Jethani S Maedica (Bucur). 2024; 18(4):576-585.

PMID: 38348070 PMC: 10859199. DOI: 10.26574/maedica.2023.18.4.576.


Notable Enhancement of Facial Scarring Following Autologous Melanocyte-Keratinocyte Transplantation and NUVB Therapy: A Case Report.

Nilforoushzadeh M, Nouri M, Alavi S, Amirkhani M, Zare S, Alavi Rad E J Lasers Med Sci. 2023; 13:e78.

PMID: 37041771 PMC: 10082892. DOI: 10.34172/jlms.2022.78.


Current Status of Cell-Based Therapies for Vitiligo.

Domaszewska-Szostek A, Polak A, Slupecka-Ziemilska M, Krzyzanowska M, Puzianowska-Kuznicka M Int J Mol Sci. 2023; 24(4).

PMID: 36834766 PMC: 9964504. DOI: 10.3390/ijms24043357.


A comparative study of efficacy of split-thickness skin grafting versus autologous melanocyte transfer in the management of stable vitiligo.

Chopra A, Lekshmipriya K Med J Armed Forces India. 2022; 78(Suppl 1):S42-S48.

PMID: 36147438 PMC: 9485736. DOI: 10.1016/j.mjafi.2020.06.007.